Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Augmentation with typical antipsychotics for patients who partially respond to antipsychotics
D. Mazeh
,
Y. Melamed
Clinical Departments
Psychiatry
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Augmentation with typical antipsychotics for patients who partially respond to antipsychotics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antipsychotics
100%
Clozapine
100%
Typical Antipsychotics
100%
Olanzapine
100%
Haloperidol
75%
Sulpiride
75%
Serotonin
50%
Dopamine Antagonist
50%
Zuclopenthixol
50%
Israel
25%
Schizophrenia
25%
Psychotic Patients
25%
Number of Patients
25%
Antipsychotic Activity
25%
D2 Receptor
25%
Low Affinity
25%
Patient Benefit
25%
Clinical Significance
25%
New Drugs
25%
D2 Antagonist
25%
Combination Regimen
25%
5-HT2
25%
Neuroscience
Typical Antipsychotic
100%
Clozapine
100%
Olanzapine
100%
Sulpiride
75%
Levosulpiride
75%
Haloperidol
75%
Serotonin
50%
Dopamine Antagonist
50%
Zuclopenthixol
50%
Receptor
50%
Antipsychotic
50%
D2 Antagonists
25%
Pharmacology, Toxicology and Pharmaceutical Science
Typical Antipsychotic
100%
Clozapine
100%
Olanzapine
100%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
75%
Sulpiride
75%
Serotonin
50%
Receptor
50%
Dopamine Receptor Blocking Agent
50%
Zuclopenthixol
50%
Antipsychotic
25%
Antipsychotic Drug
25%